ArticleJournal of cancer research and clinical oncology2019

CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.

Yue Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.